Activation of Rac1 by Src-dependent phosphorylation of Dock180 Y1811 mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans

Haizhong Feng, Bo Hu, Kun Wei Liu, Yanxin Li, Xinghua Lu, Tao Cheng, Jia Jean Yiin, Songjian Lu, Susan Keezer, Tim Fenton, Frank B. Furnari, Ronald L. Hamilton, Kristiina Vuori, Jann N. Sarkaria, Motoo Nagane, Ryo Nishikawa, Webster K. Cavenee, Shi Yuan Cheng

Research output: Contribution to journalArticlepeer-review

90 Scopus citations


Two hallmarks of glioblastoma multiforme, the most common malignant brain cancer in humans, are aggressive growth and the ability of single glioma cells to disperse throughout the brain. These characteristics render tumors resistant to current therapies and account for the poor prognosis of patients. Although it is known that oncogenic signaling caused by overexpression of genes such as PDGFRA is responsible for robust glioma growth and cell infiltration, the mechanisms underlying glioblastoma malignancy remain largely elusive. Here, we report that PDGFRα signaling in glioblastomas leads to Src-dependent phosphorylation of the guanine nucleotide exchange factor Dock180 at tyrosine 1811 (Dock180 Y1811) that results in activation of the GTPase Rac1 and subsequent cell growth and invasion. In human glioma cells, knockdown of Dock180 and reversion with an RNAi-resistant Dock180 Y1811F abrogated, whereas an RNAi-resistant Dock180 WT rescued, PDGFRα-promoted glioma growth, survival, and invasion. Phosphorylation of Dock180 Y1811 enhanced its association with CrkII and p130 Cas, causing activation of Rac1 and consequent cell motility. Dock180 also associated with PDGFRα to promote cell migration. Finally, phosphorylated Dock180 Y1811 was detected in clinical samples of gliomas and various types of human cancers, and coexpression of phosphorylated Dock180 Y1811, phosphorylated Src Y418, and PDGFRα was predictive of extremely poor prognosis of patients with gliomas. Taken together, our findings provide insight into PDGFRα-stimulated gliomagenesis and suggest that phosphorylated Dock180 Y1811 contributes to activation of Rac1 in human cancers with PDGFRA amplification.

Original languageEnglish (US)
Pages (from-to)4670-4684
Number of pages15
JournalJournal of Clinical Investigation
Issue number12
StatePublished - Dec 1 2011

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Activation of Rac1 by Src-dependent phosphorylation of Dock180 Y1811 mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans'. Together they form a unique fingerprint.

Cite this